About

We are interested in having a competitive edge in the marketplace, through mergers & acquisitions, collaborations, and strategic alliances with specific partners.

KRTL Holding Group Inc. operates its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp. Each company has its focus on specific industries including bio and Agri-Technology, to International Trade and Distribution of these technologies and services. This strategy allows KRTL Holding Group to capitalize on investment opportunities, and partnerships, creating value for its shareholders.

KRTL Biotech Inc., a wholly owned subsidiary of KRTL Holding Group, Inc. (OTC: KRTL), is a research and development company that has obtained a Ministry of Food and Drug Safety (MFDS), formerly known as the Korea Food & Drug Administration (KFDA) approval for psilocybin and CBD research. KRTL Biotech is looking to collaborate and partner with universities and biotech companies to facilitate this venture.

KRTL International Corp., a wholly owned subsidiary of KRTL Holding Group Inc. (OTC: KRTL), is an organization recently designated as a foreign advisor for the Industrial Hemp Special Regulatory Free Zone in South Korea. This opportunity has opened up partnerships for a seed bank development program with royalty potential, introduction of an exclusive distribution agreement for THC remediation technology, and an agreement with exclusive rights to our clients for the utilization of satellite imaging to identify soil quality conditions for farming operations including crop disease detection, vegetation growth and health metrics metals stressed vegetation, and forage as some examples.